Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis - PubMed (original) (raw)
P J Orchard, C Sobacchi, S Giliani, M Abinun, J P Mattsson, D J Keeling, A K Andersson, P Wallbrandt, L Zecca, L D Notarangelo, P Vezzoni, A Villa
Affiliations
- PMID: 10888887
- DOI: 10.1038/77131
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis
A Frattini et al. Nat Genet. 2000 Jul.
Abstract
Osteopetrosis includes a group of inherited diseases in which inadequate bone resorption is caused by osteoclast dysfunction. Although molecular defects have been described for many animal models of osteopetrosis, the gene responsible for most cases of the severe human form of the disease (infantile malignant osteopetrosis) is unknown. Infantile malignant autosomal recessive osteopetrosis (MIM 259700) is a severe bone disease with a fatal outcome, generally within the first decade of life. Osteoclasts are present in normal or elevated numbers in individuals affected by autosomal recessive osteopetrosis, suggesting that the defect is not in osteoclast differentiation, but in a gene involved in the functional capacity of mature osteoclasts. Some of the mouse mutants have a decreased number of osteoclasts, which suggests that the defect directly interferes with osteoclast differentiation. In other mutants, it is the function of the osteoclast that seems to be affected, as they show normal or elevated numbers of non-functioning osteoclasts. Here we show that TCIRG1, encoding the osteoclast-specific 116-kD subunit of the vacuolar proton pump, is mutated in five of nine patients with a diagnosis of infantile malignant osteopetrosis. Our data indicate that mutations in TCIRG1 are a frequent cause of autosomal recessive osteopetrosis in humans.
Similar articles
- Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.
Zirngibl RA, Wang A, Yao Y, Manolson MF, Krueger J, Dupuis L, Mendoza-Londono R, Voronov I. Zirngibl RA, et al. J Cell Biochem. 2019 Oct;120(10):17180-17193. doi: 10.1002/jcb.28979. Epub 2019 May 20. J Cell Biochem. 2019. PMID: 31111556 - TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA.
Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F. Susani L, et al. Hum Mutat. 2004 Sep;24(3):225-35. doi: 10.1002/humu.20076. Hum Mutat. 2004. PMID: 15300850 - As little as needed: the extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene.
Sobacchi C, Pangrazio A, Lopez AG, Gomez DP, Caldana ME, Susani L, Vezzoni P, Villa A. Sobacchi C, et al. J Bone Miner Res. 2014 Jul;29(7):1646-50. doi: 10.1002/jbmr.2203. J Bone Miner Res. 2014. PMID: 24535816 Free PMC article. - Human osteopetroses and the osteoclast V-H+-ATPase enzyme system.
Ogbureke KU, Zhao Q, Li YP. Ogbureke KU, et al. Front Biosci. 2005 Sep 1;10:2940-54. doi: 10.2741/1750. Front Biosci. 2005. PMID: 15970548 Review. - Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor.
Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C. Villa A, et al. Calcif Tissue Int. 2009 Jan;84(1):1-12. doi: 10.1007/s00223-008-9196-4. Epub 2008 Dec 12. Calcif Tissue Int. 2009. PMID: 19082854 Review.
Cited by
- The membrane domain of vacuolar H(+)ATPase: a crucial player in neurotransmitter exocytotic release.
Morel N, Poëa-Guyon S. Morel N, et al. Cell Mol Life Sci. 2015 Jul;72(13):2561-73. doi: 10.1007/s00018-015-1886-2. Epub 2015 Mar 21. Cell Mol Life Sci. 2015. PMID: 25795337 Free PMC article. Review. - V-ATPase functions in normal and disease processes.
Hinton A, Bond S, Forgac M. Hinton A, et al. Pflugers Arch. 2009 Jan;457(3):589-98. doi: 10.1007/s00424-007-0382-4. Epub 2007 Nov 20. Pflugers Arch. 2009. PMID: 18026982 Review. - Regulation and isoform function of the V-ATPases.
Toei M, Saum R, Forgac M. Toei M, et al. Biochemistry. 2010 Jun 15;49(23):4715-23. doi: 10.1021/bi100397s. Biochemistry. 2010. PMID: 20450191 Free PMC article. Review. - V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.
Duan X, Yang S, Zhang L, Yang T. Duan X, et al. Theranostics. 2018 Oct 26;8(19):5379-5399. doi: 10.7150/thno.28391. eCollection 2018. Theranostics. 2018. PMID: 30555553 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases